114 related articles for article (PubMed ID: 6390857)
1. High-dose versus low-dose steroid therapy in conjunction with rabbit anti-human lymphocyte serum: flow cytometric monitoring of lymphocyte parameters.
Green WF; Niblack GD; Richie RE; Johnson HK; MacDonell RC; Tallent MB
Transplant Proc; 1984 Dec; 16(6):1517-9. PubMed ID: 6390857
[No Abstract] [Full Text] [Related]
2. The adjunctive value of equine antithymocyte membrane globulin in a randomized study of patients undergoing cadaveric renal transplantation.
Diethelm AG; Blackstone E; Whelchel JD; Pass RF; Chambers L; Phillips SJ; Thiry C
Transplant Proc; 1979 Mar; 11(1):27-30. PubMed ID: 377644
[No Abstract] [Full Text] [Related]
3. Sensitive monitoring of polyclonal antilymphocyte agents in renal transplantation.
Clark KR; Taylor RM; Forsythe JL
Clin Transpl; 1993; ():267-74. PubMed ID: 7918160
[TBL] [Abstract][Full Text] [Related]
4. Trends in immunosuppression for kidney transplantation.
Butt KM; Zielinski CM; Parsa I; Elberg AJ; Wechter W; Kountz SL
Kidney Int Suppl; 1978 Jun; (8):S95-8. PubMed ID: 357820
[No Abstract] [Full Text] [Related]
5. Effective monitoring and modulation of immune reactivity in allograft recipients.
Thomas F; Lee HM; Thomas J; Mendez-Picon G
Proc Clin Dial Transplant Forum; 1976 Nov 19-22; 6():20-6. PubMed ID: 801063
[TBL] [Abstract][Full Text] [Related]
6. Individualization of recipient immunosuppression by use of in vitro monitoring parameters.
Thomas F; Thomas J; Mendez G; Lee HM; Lower R
Transplant Proc; 1978 Sep; 10(3):621-5. PubMed ID: 362647
[No Abstract] [Full Text] [Related]
7. Wide field low-dose total lymphoid irradiation in clinical kidney transplantation.
Myburgh JA; Meyers AM; Botha JR; Thomson PD; Smit JA; Browde S; Lakier R
Transplant Proc; 1987 Feb; 19(1 Pt 3):1974-7. PubMed ID: 3547902
[No Abstract] [Full Text] [Related]
8. In vivo - in vitro correlates of antithymocyte globulin (ATG) immunosuppression in the human.
Thomas F; Berry R; Mendez-Picon G; Thomas J; Lower RR; Lee HM
Proc Clin Dial Transplant Forum; 1978 Nov 18-20; 8():56-61. PubMed ID: 386321
[No Abstract] [Full Text] [Related]
9. Use of rabbit ATG in cadaver kidney transplantation: an updated report with consideration of presensitized recipients.
Davis RC; Nabseth DC; Olsson CA; Idelson BA; Schmitt GW; Cho SI; Mannick JA
Transplant Proc; 1974 Dec; 6(4 Suppl 1):67-70. PubMed ID: 4612906
[No Abstract] [Full Text] [Related]
10. Preliminary transplant results obtained in a clinical trial of whole rabbit anti-human lymphocyte serum.
Niblack GD; Johnson HK; Richie RE; Tallent MB; MacDonell R; Turner B
Proc Clin Dial Transplant Forum; 1979; 9():95-8. PubMed ID: 399521
[No Abstract] [Full Text] [Related]
11. Monitoring of renal allografts under immunosuppression.
Hammer C
Z Exp Chir Transplant Kunstliche Organe; 1986; 19(6):340-2. PubMed ID: 3548110
[No Abstract] [Full Text] [Related]
12. Preliminary studies on antithymocyte globulin.
Orlowski T; SkopiĆska E; Kossowska-Paul B; Wasik M; Wojtulewicz-Kurkus J; Klopotowska E; Tupalska B; Filipowicz Z
Pol Med J; 1971; 10(2):400-7. PubMed ID: 4997629
[No Abstract] [Full Text] [Related]
13. Adjuncts to triple-drug therapy after cardiac transplantation: a comparison of Nashville rabbit antithymocyte serum to OKT3.
Aziz S; Kruse AP; Roby PV; Allen MD; Khan K; Fishbein D
Transplant Proc; 1994 Oct; 26(5):2721-3. PubMed ID: 7940852
[No Abstract] [Full Text] [Related]
14. Multicenter comparison of rejection reversal: rabbit anti-human lymphocyte serum (ATS) versus horse anti-human lymphocyte globulin (ATGAM).
Johnson K; Niblack G; Richie R; MacDonell R; Nylander W; Walker P; Sterling W; Ross G; Humphries A; Peterson D
Transplant Proc; 1989 Feb; 21(1 Pt 2):1734-5. PubMed ID: 2652567
[No Abstract] [Full Text] [Related]
15. The influence of immunosuppressive drugs on human immunocompetence.
ten Berge RJ; Schellekens PT; van Boxtel CJ; Sauerwein HP; Wilmink JM
Scand J Urol Nephrol Suppl; 1985; 92():3. PubMed ID: 3914059
[No Abstract] [Full Text] [Related]
16. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience.
Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Bayoumy A; Sobh M; Ghoneim M
Iran J Kidney Dis; 2008 Jan; 2(1):34-9. PubMed ID: 19367007
[TBL] [Abstract][Full Text] [Related]
17. Sequential biological immunosuppression. Induction therapy with rabbit antithymocyte globulin.
Guttmann RD; Flemming C
Clin Transplant; 1997 Jun; 11(3):185-92. PubMed ID: 9193840
[TBL] [Abstract][Full Text] [Related]
18. A pilot study of immunosuppression minimization after pancreas-kidney transplantation utilizing thymoglobulin induction and sirolimus maintenance therapy.
Knight RJ; Kerman RH; McKissick E; Lawless A; Podder H; Katz S; Van Buren CT; Kahan BD
Transplant Proc; 2005 Oct; 37(8):3538-41. PubMed ID: 16298653
[TBL] [Abstract][Full Text] [Related]
19. Randomized steroid therapy of human kidney transplant rejection.
Kauffman HM; Stromstad SA; Sampson D; Stawicki AT
Transplant Proc; 1979 Mar; 11(1):36-8. PubMed ID: 377656
[No Abstract] [Full Text] [Related]
20. Clinical evaluation of the immunogenicity of horse and rabbit antihuman lymphocyte globulin in renal transplantation.
Cerilli GJ; Miller A; Hattan D
Surg Forum; 1970; 21():250-2. PubMed ID: 4936976
[No Abstract] [Full Text] [Related]
[Next] [New Search]